A study using a Korean database found that COVID-19 infection raised long-term risks for various autoimmune and ...

We recently compiled a list of the 10 Best Genomics Stocks To Buy Right Now. In this article, we are going to take a look at ...

Biotech stocks, including Regeneron, have seen significant declines due to regulatory and political uncertainty, presenting a potential buying opportunity as seller exhaustion nears. Regeneron's 40% ...

Vyriad, Inc., a clinical-stage biotechnology company developing the next generation of targeted genetic therapies, today announced a strategic collaboration with Novartis to discover and develop in ...

The number of international students at Princeton has grown in recent years, but struggles with the American application ...

It takes a cracked mindset to name a cracked pot with no scientific training to head the agency that oversees 11 agencies ...

Finally, the number of opportunities in the biosimilars space is very high — there are more than 300 biologics in the market, ...

Treatment with metformin was associated with a reduction in asthma attacks among patients with asthma and type 2 diabetes, with additional reductions observed with the use of GLP-1 receptor agonists, ...

Here’s a stock picking tool you might not have thought about. It’s called the PEG ratio. The PEG ratio is a ratio of two ...

Regeneron's CD20xCD3 bispecific antibody for non-Hodgin lymphoma (NHL) has been approved in Europe, five months after it was turned down by the FDA in the US. Ordspono (odronextamab) has been ...

Trump Defies the #MeToo Movement With Cabinet Picks Facing Accusations Donald Trump, who was found liable for sexual abuse last year, appears determined to force a fight over the role of such ...